Show simple item record

dc.contributor.authorWhinnett, Zachary I
dc.contributor.authorSohaib, S M Afzal
dc.contributor.authorJones, Siana
dc.contributor.authorKyriacou, Andreas
dc.contributor.authorMarch, Katherine
dc.contributor.authorCoady, Emma
dc.contributor.authorMayet, Jamil
dc.contributor.authorHughes, Alun D
dc.contributor.authorFrenneaux, Michael
dc.contributor.authorFrancis, Darrel P
dc.contributor.authorBRAVO Investigators
dc.date.accessioned2014-12-18T10:31:01Z
dc.date.available2014-12-18T10:31:01Z
dc.date.issued2014-04-03
dc.identifier.citationWhinnett , Z I , Sohaib , S M A , Jones , S , Kyriacou , A , March , K , Coady , E , Mayet , J , Hughes , A D , Frenneaux , M , Francis , D P & BRAVO Investigators 2014 , ' British randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpoints ' , BMC Cardiovascular Disorders , vol. 14 , 42 . https://doi.org/10.1186/1471-2261-14-42en
dc.identifier.otherPURE: 45254353
dc.identifier.otherPURE UUID: a85c11b5-a136-448e-9cd8-41df3bf56f52
dc.identifier.otherPubMed: 24693953
dc.identifier.otherScopus: 84897964065
dc.identifier.urihttp://hdl.handle.net/2164/4113
dc.language.isoeng
dc.relation.ispartofBMC Cardiovascular Disordersen
dc.rightsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectBiological Markersen
dc.subjectBlood Pressure Determinationen
dc.subjectCardiac Resynchronization Therapyen
dc.subjectCardiac Resynchronization Therapy Devicesen
dc.subjectClinical Protocolsen
dc.subjectCross-Over Studiesen
dc.subjectEchocardiography, Doppleren
dc.subjectExercise Testen
dc.subjectExercise Toleranceen
dc.subjectGreat Britainen
dc.subjectHeart Failureen
dc.subjectHemodynamicsen
dc.subjectHumansen
dc.subjectNatriuretic Peptide, Brainen
dc.subjectPeptide Fragmentsen
dc.subjectPhotoplethysmographyen
dc.subjectPredictive Value of Testsen
dc.subjectQuality of Lifeen
dc.subjectQuestionnairesen
dc.subjectRecovery of Functionen
dc.subjectResearch Designen
dc.subjectTime Factorsen
dc.subjectTreatment Outcomeen
dc.subjectVentricular Function, Leften
dc.subjectVentricular Remodelingen
dc.subjectOptimizationen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleBritish randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpointsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/1471-2261-14-42


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record